THE European Commission has
announced the apporval of Cialis
(tadalafil) 5mg tablets for the
treatment of benign prostatic
hyperplasia.
The approval is for once daily use,
and complements the existing use
of Cialis for erectile dysfunction.The above article was sent to subscribers in Pharmacy Daily's issue from 31 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Oct 12
THE Australian Government has lowered the age of eligibility for its free National Bowel Cancer Screening Program (NBCSP) to 45, unlocking access to the test kits to more than 1.6 million Australians.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.